Cardiovascular diseases continue to be one of the leading causes of death in general population, despite preventive measures in health care. Among subjects with renal impairment, cardiovas-cular mortality is up to 30 times higher than in the general population. The detection of subjects who are at risk for cardiovascular disease or deterioration of renal function is warranted. A number of classical risk factors are usually advocated to be of value in cardiovascular and renal medicine namely blood pressure, cholesterol, smoking and blood glucose levels. The thesis concerns the role of C-reactive protein and albuminuria, two novel risk markers, in the prediction of cardiovascular and renal disease progression. It has been proposed that both m...
Chronic kidney disease (CKD) and its associated morbidity pose a worldwide health problem. As well a...
Cardiovascular disease is the leading cause of death in the general population; traditional risk fac...
Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment? Albuminur...
Cardiovascular diseases continue to be one of the leading causes of death in general population, des...
Cardiovascular diseases continue to be one of the leading causes of death in general population, des...
C-reactive protein (CRP) and urinary albumin excretion are both determinants of cardiovascular risk....
C-reactive protein (CRP) and urinary albumin excretion are both determinants of cardiovascular risk....
Aim: It is important to explore predictive markers other than conventional cardiovascular risk facto...
Cardiovascular disease is the leading cause of death in patients with end-stage renal disease. Besid...
End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the mi...
C-reactive protein is associated with renal function abnormalities in a non-diabetic population.Back...
Background. C-reactive protein (CRP) has recently been introduced in cardiovascular medicine as a pr...
Inflammation and chronic kidney disease predict cardiovascular events. Here we evaluated markers of ...
C-reactive protein (CRP) and microalbuminuria (MA) have been identified as risk markers for cardiova...
An elevated urinary albumin excretion rate (UAER) is associated with an increased risk of cardiovasc...
Chronic kidney disease (CKD) and its associated morbidity pose a worldwide health problem. As well a...
Cardiovascular disease is the leading cause of death in the general population; traditional risk fac...
Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment? Albuminur...
Cardiovascular diseases continue to be one of the leading causes of death in general population, des...
Cardiovascular diseases continue to be one of the leading causes of death in general population, des...
C-reactive protein (CRP) and urinary albumin excretion are both determinants of cardiovascular risk....
C-reactive protein (CRP) and urinary albumin excretion are both determinants of cardiovascular risk....
Aim: It is important to explore predictive markers other than conventional cardiovascular risk facto...
Cardiovascular disease is the leading cause of death in patients with end-stage renal disease. Besid...
End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the mi...
C-reactive protein is associated with renal function abnormalities in a non-diabetic population.Back...
Background. C-reactive protein (CRP) has recently been introduced in cardiovascular medicine as a pr...
Inflammation and chronic kidney disease predict cardiovascular events. Here we evaluated markers of ...
C-reactive protein (CRP) and microalbuminuria (MA) have been identified as risk markers for cardiova...
An elevated urinary albumin excretion rate (UAER) is associated with an increased risk of cardiovasc...
Chronic kidney disease (CKD) and its associated morbidity pose a worldwide health problem. As well a...
Cardiovascular disease is the leading cause of death in the general population; traditional risk fac...
Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment? Albuminur...